Orex Pharma Private Limited - Company Profile

Q: Who are the current directors of Orex Pharma Private Limited?

The current directors of Orex Pharma Private Limited are Baburao Krishnaji Pisal, Mangesh Baburao Pisal, Kiran Baburao Pisal.

It is a pharma private limited company based in Thane, Maharashtra, India, established in 1979.

1979 Thane, Maharashtra, India Active

Last Updated: December 23, 2025

Access Report

About Orex Pharma Private Limited

Orex Pharma Private Limited, a active private limited company, was established on 20 June 1979 in Thane, Maharashtra, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U99999MH1979PTC021403. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.10 Cr and a paid-up capital of ₹2.29 Cr.

It upholds a compliant status. Employing 138 professional, Its leadership includes Baburao Krishnaji Pisal (Managing Director), Mangesh Baburao Pisal (Director), Kiran Baburao Pisal (Director). Past directors included Suman Baburao Pisal, Kiran Baburao Pisal. It holds ₹47.34 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Pisal House, Nakhwa Compound, Stadium Road, Thane (W),, Thane, Maharashtra, 400601.

Company Details

CIN/LLPIN
U99999MH1979PTC021403
Registration Number
021403
Incorporation Date
20 June 1979
Authorized Capital
₹3.10 Cr
Paid-Up Capital
₹2.29 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 3.10 Cr as on 23-12-2025
Paid Up Capital ₹ 2.29 Cr as on 23-12-2025
Company Age 46 Year, 7 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 47.34 Cr as on 23-12-2025
Revenue Growth **** 10.13% (FY 2024)
Profit Growth **** -13.96% (FY 2024)
Ebitda **** 17.15% (FY 2024)
Net Worth 11.76% (FY 2024)
Total Assets -1.32% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Orex Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Orex Pharma Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Baburao Krishnaji Pisal	Managing Director	20 Jun 1979	Current
Mangesh Baburao Pisal	Director	01 Oct 2004	Current
Kiran Baburao Pisal	Director	01 Oct 2010	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	15 Jun 2018	Past
Pramod Abcsdd	Additional Director	30 Sep 2011	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Orex Pharma.

Orex Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 10.13% increase. The company also saw a substantial fall in profitability, with a 13.96% decrease in profit. The company's net worth Soared by an impressive increase of 11.76%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

10.13%

*******

Revenue from Operations

*******

10.11%

*******

Total Assets

*******

-1.32%

*******

Profit or Loss

*******

-13.96%

*******

Net Worth

*******

11.76%

*******

EBITDA

*******

17.15%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Orex Pharma?

In 2024, Orex Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹473,422,725.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Others : 36.60 Cr
Bombay Mercantile Co-Operative Bank Limited : 8.45 Cr
Bombay Mercantile Co-Operative Bank Limited. : 1.15 Cr
Bombay Mercantile Co-Operative Bank Ltd. : 0.50 Cr
Hdfc Bank Limited : 0.47 Cr
Others : 0.18 Cr

Latest Charge Details

Date	Lender	Amount	Status
21 Nov 2025	Hdfc Bank Limited	₹1.54 M	Open
16 Jun 2025	Others	₹2.50 M	Open
31 Jan 2024	Others	₹2.00 Cr	Open
10 Oct 2022	Others	₹7.50 M	Open
10 Oct 2022	Others	₹6.24 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Orex Pharma?

Orex Pharma has a workforce of 138 employees as of Mar 04, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Orex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orex Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Orex Pharma

Recent Activity within the Organization

Charges

Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.15 Cr with Charge ID 101197412 was registered on 21 Nov 2025. was documented.
21 Nov 2025
Annual General Meeting

Orex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
30 Sep 2025
Charges

A charge with Others of Rs. 11.00 Cr registered on 10 Oct 2022 with Charge ID 100622406 was modified on 22 Sep 2025. was recorded as a recent event.
22 Sep 2025
Charges

The activity A charge with Others amounted to Rs. 0.25 Cr with Charge ID 101124604 was registered on 16 Jun 2025. was completed.
16 Jun 2025
Balance Sheet

Progress on Orex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
31 Mar 2025
Charges

A charge with Others of Rs. 2.00 Cr registered on 31 Jan 2024 with Charge ID 100864811 was modified on 21 Mar 2024. was recorded as a recent event.
21 Mar 2024

Explore recent activity and updates - View Recent Activity